Clearpoint Neuro Stock Market Value
| CLPT Stock | USD 11.05 0.06 0.54% |
| Symbol | Clearpoint |
Clearpoint Neuro Price To Book Ratio
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Clearpoint Neuro. If investors know Clearpoint will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Clearpoint Neuro listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.70) | Revenue Per Share 1.099 | Quarterly Revenue Growth 0.321 | Return On Assets (0.23) | Return On Equity (0.60) |
The market value of Clearpoint Neuro is measured differently than its book value, which is the value of Clearpoint that is recorded on the company's balance sheet. Investors also form their own opinion of Clearpoint Neuro's value that differs from its market value or its book value, called intrinsic value, which is Clearpoint Neuro's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Clearpoint Neuro's market value can be influenced by many factors that don't directly affect Clearpoint Neuro's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Clearpoint Neuro's value and its price as these two are different measures arrived at by different means. Investors typically determine if Clearpoint Neuro is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Clearpoint Neuro's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Clearpoint Neuro 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Clearpoint Neuro's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Clearpoint Neuro.
| 08/28/2024 |
| 09/27/2024 |
If you would invest 0.00 in Clearpoint Neuro on August 28, 2024 and sell it all today you would earn a total of 0.00 from holding Clearpoint Neuro or generate 0.0% return on investment in Clearpoint Neuro over 30 days. Clearpoint Neuro is related to or competes with Telesis Bio, Avita Medical, Sight Sciences, Treace Medical, Neuropace, Inogen, and SurModics. ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States More
Clearpoint Neuro Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Clearpoint Neuro's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Clearpoint Neuro upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.04 | |||
| Information Ratio | 0.1696 | |||
| Maximum Drawdown | 47.7 | |||
| Value At Risk | (5.11) | |||
| Potential Upside | 10.14 |
Clearpoint Neuro Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Clearpoint Neuro's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Clearpoint Neuro's standard deviation. In reality, there are many statistical measures that can use Clearpoint Neuro historical prices to predict the future Clearpoint Neuro's volatility.| Risk Adjusted Performance | 0.1595 | |||
| Jensen Alpha | 0.8798 | |||
| Total Risk Alpha | 0.3428 | |||
| Sortino Ratio | 0.3667 | |||
| Treynor Ratio | 0.385 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Clearpoint Neuro's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Clearpoint Neuro Backtested Returns
Clearpoint Neuro is slightly risky given 3 months investment horizon. Clearpoint Neuro secures Sharpe Ratio (or Efficiency) of 0.21, which signifies that the company had a 0.21% return per unit of standard deviation over the last 3 months. We were able to interpolate data for twenty-seven different technical indicators, which can help you to evaluate if expected returns of 1.38% are justified by taking the suggested risk. Use Clearpoint Neuro mean deviation of 3.92, and Risk Adjusted Performance of 0.1595 to evaluate company specific risk that cannot be diversified away. Clearpoint Neuro holds a performance score of 16 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 3.17, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Clearpoint Neuro will likely underperform. Use Clearpoint Neuro maximum drawdown, and the relationship between the information ratio and expected short fall , to analyze future returns on Clearpoint Neuro.
Auto-correlation | 0.59 |
Modest predictability
Clearpoint Neuro has modest predictability. Overlapping area represents the amount of predictability between Clearpoint Neuro time series from 28th of August 2024 to 12th of September 2024 and 12th of September 2024 to 27th of September 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Clearpoint Neuro price movement. The serial correlation of 0.59 indicates that roughly 59.0% of current Clearpoint Neuro price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.59 | |
| Spearman Rank Test | 0.66 | |
| Residual Average | 0.0 | |
| Price Variance | 0.23 |
Clearpoint Neuro lagged returns against current returns
Autocorrelation, which is Clearpoint Neuro stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Clearpoint Neuro's stock expected returns. We can calculate the autocorrelation of Clearpoint Neuro returns to help us make a trade decision. For example, suppose you find that Clearpoint Neuro has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Clearpoint Neuro regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Clearpoint Neuro stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Clearpoint Neuro stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Clearpoint Neuro stock over time.
Current vs Lagged Prices |
| Timeline |
Clearpoint Neuro Lagged Returns
When evaluating Clearpoint Neuro's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Clearpoint Neuro stock have on its future price. Clearpoint Neuro autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Clearpoint Neuro autocorrelation shows the relationship between Clearpoint Neuro stock current value and its past values and can show if there is a momentum factor associated with investing in Clearpoint Neuro.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Clearpoint Stock Analysis
When running Clearpoint Neuro's price analysis, check to measure Clearpoint Neuro's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Clearpoint Neuro is operating at the current time. Most of Clearpoint Neuro's value examination focuses on studying past and present price action to predict the probability of Clearpoint Neuro's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Clearpoint Neuro's price. Additionally, you may evaluate how the addition of Clearpoint Neuro to your portfolios can decrease your overall portfolio volatility.